Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Open Access Dissertations and Theses Community
  3. Open Access Dissertations and Theses
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/9932
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorGrover, A.K.en_US
dc.contributor.authorSzewczyk, Maria Magdalenaen_US
dc.date.accessioned2014-06-18T16:48:57Z-
dc.date.available2014-06-18T16:48:57Z-
dc.date.created2011-06-28en_US
dc.date.issued2011-10en_US
dc.identifier.otheropendissertations/5008en_US
dc.identifier.other6020en_US
dc.identifier.other2079329en_US
dc.identifier.urihttp://hdl.handle.net/11375/9932-
dc.description.abstract<p>This work used biotechnology to invent new caloxins - allosteric peptide inhibitors of plasma membrane Ca<sup>2+ </sup>pumps (PMCA) needed to understand the Ca<sup>2+ </sup>signalling in coronary artery.</p> <p>PMCA are encoded by genes PMCA1-4. Defects in PMCA expression have been associated with several pathologies. The major objectives of my thesis were to determine the expression of PMCA isoforms in the smooth muscle and the endothelium of coronary artery and to invent high affinity and specificity caloxins for the isoforms present in these tissues.</p> <p>In Aim 1 it was determined that the total PMCA protein and activity was much greater in smooth muscle than in endothelium. Both tissues expressed only PMCA1 and PMCA4, with PMCA4 > PMCA1 in smooth muscle and PMCA1 > PMCA4 in endothelium. Therefore, the search for PMCA1 and 4 selective caloxins using phage display technique was conducted.</p> <p>Aim 2 was to invent PMCA1 selective inhibitors. Caloxin 1b3 was invented as the first known PMCA1 selective inhibitor. It inhibited PMCA1 Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase with higher affinity than PMCA2, 3 or 4. Aims 1 and 2 were consistent with the greater potency of caloxin 1b3 than a known PMCA4 selective caloxin 1b1 in increasing cytosolic Ca<sup>2+</sup> concentration in endothelial cells.</p> <p>Aim 3 was to obtain ultrahigh selectivity and affinity PMCA4 bidentate inhibitor using the previously invented PMCA4 selective caloxins 1c2 and 1b2. In the first step the affinity of caloxin 1b2 was improved by limited mutagenesis to obtain caloxin 1c4. Caloxin 1c4 had 5-6 times higher affinity than caloxin 1b2 for inhibiting PMCA4 activity. Optimization of the bidentate caloxins from caloxin 1c2 and 1c4 was also attempted.</p> <p>The novel caloxins may aid in elucidating the role of PMCA1 and PMCA4 in the physiology and pathophysiology of coronary artery and other tissues.</p>en_US
dc.subjectendotheliumen_US
dc.subjectsmooth muscleen_US
dc.subjectPMCAen_US
dc.subjectcalcium pumpen_US
dc.subjectinhibitoren_US
dc.subjectcaloxinen_US
dc.subjectphage displayen_US
dc.subjectcoronary arteryen_US
dc.subjectMolecular Biologyen_US
dc.subjectMolecular Biologyen_US
dc.titleBIOTECHNOLOGICAL INVENTION OF CALOXINS - A NOVEL CLASS OF ALLOSTERIC INHIBITORS SPECIFIC FOR PLASMA MEMBRANE CALCIUM PUMP ISOFORMSen_US
dc.typethesisen_US
dc.contributor.departmentBiologyen_US
dc.description.degreeDoctor of Philosophy (PhD)en_US
Appears in Collections:Open Access Dissertations and Theses

Files in This Item:
File SizeFormat 
fulltext.pdf
Open Access
1.71 MBAdobe PDFView/Open
Show simple item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue